JCM | Free Full-Text | The CHA2DS2-VASc Score Predicts Major Bleeding in Non-Valvular Atrial Fibrillation Patients Who Take Oral Anticoagulants
Figure 1 from Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? | Semantic Scholar
EMNote.org - EMNote
Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2- VASc Risk Factor Be Anticoagulated? | Stroke
Moving Beyond Warfarin—Are We Ready?: A Review of the Efficacy and Safety of Novel Anticoagulant Agents Compared to Warfarin for the Management of Atrial Fibrillation in Older Adults | Journal of Gerontological
Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología
CHA2DS2-VASc score stratifies mortality risk in patients with and without atrial fibrillation | Open Heart
What If My CHA2DS2-VASc Score Is One? – EP Studios
Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2- VASc Score 1 in Men, 2 in Women) Be Anticoagulated? | Circulation
Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis - ScienceDirect
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation? | Journal of the American College of Cardiology
EHRAPresident on Twitter: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of
Table 2 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar
CHA2DS2-VaSc Score – Primary Care Pharmacy Consortium
Case Clinic: A 67-Year-Old White Male Patient With Atrial Fibrillation Risk Factors - Page 2 of 4 - Clinical Advisor
Anticoagulation for Atrial Fibrillation - CHA2DS2-VASc I ... | GrepMed
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After G
Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study | PLOS ONE